Literature DB >> 12208968

Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established.

Thomas B Macnaughton1, Michael M C Lai.   

Abstract

Moderation of hepatitis delta virus (HDV) replication is a likely prerequisite in the establishment of chronic infections and is thought to be mediated by the intracellular accumulation of large hepatitis delta antigen (L-HDAg). The regulatory role of this protein was suggested from several studies showing that cotransfection of plasmid cDNAs expressing both L-HDAg and HDV RNA results in a potent inhibition of HDV RNA replication. However, since this approach differs significantly from natural HDV infections, where HDV RNA replication is initiated from an RNA template, and L-HDAg appears only late in the replication cycle, it remains unclear whether L-HDAg can modulate HDV RNA replication in the natural HDV replication cycle. In this study, we investigated the effect of L-HDAg, produced as a result of the natural HDV RNA editing event, on HDV RNA replication. The results showed that following cDNA-free HDV RNA transfection, a steady-state level of RNA was established at 3 to 4 days posttransfection. The same level of HDV RNA was reached when a mutant HDV genome unable to make L-HDAg was used, suggesting that L-HDAg did not play a role. The rates of HDV RNA synthesis, as measured by metabolic labeling experiments, were identical at 4 and 8 days posttransfection and in the wild type and the L-HDAg-deficient mutant. We further examined the effect of overexpression of L-HDAg at various stages of the HDV replication cycle, showing that HDV RNA synthesis was resistant to L-HDAg when it was overexpressed 3 days after HDV RNA replication had initiated. Finally, we showed that, contrary to conventional thinking, L-HDAg alone, at a certain molar ratio with HDV RNA, can initiate HDV RNA replication. Thus, L-HDAg does not inherently inhibit HDV RNA synthesis. Taken together, these results indicated that L-HDAg affects neither the rate of HDV RNA synthesis nor the final steady-state level of HDV RNA and that L-HDAg is unlikely to act as an inhibitor of HDV RNA replication in the natural HDV replication cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208968      PMCID: PMC136516          DOI: 10.1128/jvi.76.19.9910-9919.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases.

Authors:  Thomas B Macnaughton; Stephanie T Shi; Lucy E Modahl; Michael M C Lai
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.

Authors:  H J Netter; T B Macnaughton; W P Woo; R Tindle; E J Gowans
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication.

Authors:  L E Modahl; M M Lai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 5.  A replication cycle for viroids and other small infectious RNA's.

Authors:  A D Branch; H D Robertson
Journal:  Science       Date:  1984-02-03       Impact factor: 47.728

6.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

7.  Production of mRNA in Chinese hamster cells: relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences.

Authors:  M M Harpold; R M Evans; M Salditt-Georgieff; J E Darnell
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

8.  Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo.

Authors:  K S Jeng; P Y Su; M M Lai
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  Host RNA polymerase requirements for transcription of the human hepatitis delta virus genome.

Authors:  G Moraleda; J Taylor
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

View more
  13 in total

1.  By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression.

Authors:  Shuji Sato; Cromwell Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  Alternative processing of hepatitis delta virus antigenomic RNA transcripts.

Authors:  Xingcao Nie; Jinhong Chang; John M Taylor
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

3.  Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication.

Authors:  Yi-Jia Li; Michael R Stallcup; Michael M C Lai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 4.  RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus.

Authors:  Michael M C Lai
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies.

Authors:  Yi-Jia Li; Thomas Macnaughton; Lu Gao; Michael M C Lai
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis.

Authors:  Chung-Hsin Tseng; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

7.  Modification of small hepatitis delta virus antigen by SUMO protein.

Authors:  Chung-Hsin Tseng; Tai-Shan Cheng; Chiung-Yueh Shu; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

8.  Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Differential inhibition of RNA editing in hepatitis delta virus genotype III by the short and long forms of hepatitis delta antigen.

Authors:  Qiufang Cheng; Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Hepatitis delta virus RNA encoding the large delta antigen cannot sustain replication due to rapid accumulation of mutations associated with RNA editing.

Authors:  Thomas B Macnaughton; Yi-Ija Li; Alison L Doughty; Michael M C Lai
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.